3rd Party Biotechnology Industry News

Roche dived into the metabolic dysfunction-associated steatohepatitis space by agreeing [...]

Beijing QL Biopharmaceutical has shared phase 2 data on its [...]

One of the top fundraisers of 2024 is halving its [...]

California VC firm Aditum Bio is at it again, this [...]

After being touted as a potential rival to Bristol Myers [...]

Politicians scrambled to arrange the committee hearing after a string [...]

Genmab has dropped an antibody-drug conjugate picked up as part [...]

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody [...]

Flagship Pioneering’s Lila Sciences has landed a substantial $235 million [...]

CatalYm has tapped four industry leaders to take up spots [...]